Optimal Follow-up Time for Patients Treated with Hypertensive-risk Oral Chemotherapy,
Role: PI,
LLU Dept. of Pharmacy Practice,
(10/2024)
Status: Approved
Incidence of Hypertension in Patients Receiving Oral Chemotherapy in a Specialty Pharmacy Setting,
Role: PI,
LLU Dept. of Pharmacy Practice,
(10/2023)
Status: Approved